SynAct Pharma AB (OSTO:SYNACT) Price-to-Operating-Cash-Flow : (As of Jun. 15, 2024)

View and export this data going back to 2016. Start your Free Trial

What is SynAct Pharma AB Price-to-Operating-Cash-Flow?

As of today (2024-06-15), SynAct Pharma AB's share price is kr7.055. SynAct Pharma AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-2.45. Hence, SynAct Pharma AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for SynAct Pharma AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

OSTO:SYNACT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.42
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

SynAct Pharma AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was kr-0.32. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-2.45.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -27.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -23.60% per year.

During the past 8 years, SynAct Pharma AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was -2.10% per year. The lowest was -57.10% per year. And the median was -20.25% per year.

SynAct Pharma AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for SynAct Pharma AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynAct Pharma AB Price-to-Operating-Cash-Flow Chart

SynAct Pharma AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

SynAct Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of SynAct Pharma AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, SynAct Pharma AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SynAct Pharma AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynAct Pharma AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where SynAct Pharma AB's Price-to-Operating-Cash-Flow falls into.

SynAct Pharma AB Price-to-Operating-Cash-Flow Calculation

SynAct Pharma AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	7.055	/	-2.445
	=

SynAct Pharma AB's Share Price of today is kr7.055.
SynAct Pharma AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.45.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

SynAct Pharma AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of SynAct Pharma AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

SynAct Pharma AB (OSTO:SYNACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynAct Pharma AB (OSTO:SYNACT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

8F8:Germany

Address

Sheelevagen 2, Lund, SWE, 223 81

Website

https://www.synactpharma.se

SynAct Pharma AB is a clinical-stage biotech company focused on resolving inflammation through selective activation of the melanocortin system. The company has a platform technology based on a new class of drug candidates that target acute exacerbations in chronic inflammatory diseases with the primary aim of stimulating natural healing mechanisms. AP1189, the company's lead drug candidate, is being evaluated in three Phase 2 clinical programs regarding rheumatoid arthritis, idiopathic membranous glomerulonephritis and virus-induced respiratory failure.

SynAct Pharma AB (OSTO:SYNACT) Headlines

No Headlines